Issue
Alert me when new journal issues are available via or via
Editorial board page i Full-Text PDF (51 KB)
Extended abstracts
I01 Haploidentical transplantation for acute leukemia I. Cunningham pages S1-S3 Full-Text PDF (75 KB)
I02 GVHD and extracorporeal photopheresis H.T. Greinix pages S4-S6 Full-Text PDF (96 KB)
I03 Endothelium and haematopoietic stem cell transplantation E. Carreras pages S7-S9 Full-Text PDF (54 KB)
I04 Stem cell transplantation in multiple myeloma G. Gahrton pages S10-S12 Full-Text PDF (59 KB)
I05 Hematopoietic stem cell transplantation in Europe Economical and political implications A. Gratwohl, H. Baldomero, for the EBMT Activity Survey Office pages S13-S22 Full-Text PDF (1591 KB)
I06 Unusual RhD phenotypes recent advances and clinical implications G.F. K¨orm¨oczi pages S23-S25 Full-Text PDF (61 KB)
I07 Bystander immune cytolysis L.D. Petz pages S26-S29 Full-Text PDF (62 KB)
I08 Development of transfusion medicine in Europe A challenge for physicians, scientists and politicians E. Seifried, M.M. Mueller pages S30-S33 Full-Text PDF (61 KB)
I09 Thalassemia syndromes M.D. Cappellini pages S34-S35 Full-Text PDF (52 KB)
I10 Refractory iron deficiency anemia C. Hershko pages S36-S38 Full-Text PDF (65 KB)
I11 Epidemiology and risk factors for serious infections in the stem cell transplant setting C. Cordonnier, S. Maury pages S39-S42 Full-Text PDF (69 KB)
I12 Serious infections in onco-hematology and hematopoietic stem cell transplantation. Anti-infective treatment strategies J. Sinkó pages S43-S47 Full-Text PDF (70 KB)
I13 Recent advances in molecular cytogenetics of CML E. Nacheva pages S48-S51 Full-Text PDF (62 KB)
I14 Phenotypic and genotypic diagnosis of von Willebrand Disease U. Budde, R. Schneppenheim pages S52-S55 Full-Text PDF (66 KB)
I15 Necessity and benefit of thrombophilia screening? J.C.J. Eikenboom pages S56-S58 Full-Text PDF (58 KB)
I16 Hemophilia P.M. Mannucci pages S59-S60 Full-Text PDF (51 KB)
I17 Treatment of acute lymphoblastic leukemia in adults D. Hoelzer, N. G¨okbuget pages S61-S66 Full-Text PDF (90 KB)
Oral presentations
O01 Twenty-five years of clinical trials for adult Acute Myeloid Leukaemia (AML) in Australia R.M. Lowenthal, J.F. Seymour, on behalf of the Australasian Leukaemia/Lymphoma Group (ALLG) page S67 Full-Text PDF (61 KB)
O02 The effects of transporter gene polymorphisms on the immunosuppressive effects of chemotherapy in childhood acute lymphoblastic leukemia (ALL) G.T. Kovacs, D.J. Erdelyi, A. Semsei, E. Kamory, M. Csoka, A. Tordai, C. Szalai page S67 Full-Text PDF (61 KB)
O03 Genetics of acute lymphoblastic leukaemia (ALL) in childhood E. Oláh, E. Balogh, Z. Jakab, B. Bessenyei, A. Ujfalusi pages S67-S68 Full-Text PDF (71 KB)
O04 Our experience with the Hong Kong-Singapore Acute Lymphoblastic Leukaemia 97 protocol S.Y. Soh, M.Y. Chan, A.M. Tan page S68 Full-Text PDF (46 KB)
O05 Leukemic tumors in the ovary I. Cunningham page S68 Full-Text PDF (46 KB)
O06 Bortezomib+chemotherapy based salvage combinations in refractory AML, preliminary results M. Udvardy, A. Kiss, B. Telek, R. Szasz, P. Batar, G. Remenyi, E. Mehes, L. Rejto page S68 Full-Text PDF (46 KB)
O07 Dexamethasone versus methyl-prednisolone for adult acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) in patients ≤60 yrs old: final results of the EORTC ALL-4 Phase III Trial B. Labar, S. Suciu, P. Muus, R. Willemze, J.-P. Marie, G. Fillet, Z. Berneman, B. Jaksic, W. Feremans, D. Bron, H. Sinnige, M. Mistrik, G. Vreugdenhil, R. De Bock, D. Nemet, C. Gilotay, T. de Witte, S. Amadori page S69 Full-Text PDF (50 KB)
O08 Association between CYP2C9 polymorphism and warfarin dose M. Samardžija, E. Topić, M. Štefanović, L. Zibar, G. Samardžija, S. Balen, A. Včev, D. Domanović, J. Barbić, D. Petrak, V. Šišljagić page S69 Full-Text PDF (50 KB)
O09 Study of the most common inherited thrombophilias in HELLP syndrome patients P. Hupuczi, B. Nagy, B. Rigó, G. Szabó, E. Berkes, I. Sziller, Z. Papp pages S69-S70 Full-Text PDF (60 KB)
O10 Evaluation of bone mineral density in children with hemophilia: Mansoura University Children Hospital (MUCH) experience, Mansoura, Egypt N. Abdelrazik, M. Reda, M. El-Ziny, H. Rabea page S70 Full-Text PDF (48 KB)
O11 Genetic analysis of the coagulation factor VIII and IX genes in Hungarian families with haemophilia A. Bors, H. Andrikovics, A. Szilvási, Zs. Illés, A. Marosi, L. Nemes, A. Tordai page S70 Full-Text PDF (48 KB)
O12 Rare bleeding disorders in Slovakia genotype and phenotype characteristics A. Batorova, D. Horvathova, D. Jankovicova, M. Mistrik pages S70-S71 Full-Text PDF (60 KB)
O13 Ten years follow up of hereditary hemorrhagic patients in the dental practice S.P. Makris, M.P. Makris, A. Papadopoulos, P.E. Makris page S71 Full-Text PDF (47 KB)
O14 RhD positive or negative? Partial D antigen determination using gel card technique by DIAGAST D Screen system Z. Csernus, K. Siba, V. Pászthy, I. Nemes page S71 Full-Text PDF (47 KB)
O15 HCV infection and risk factors among Hungarian blood donors in colleges and universities E. Barabás, Z. Péterfi page S72 Full-Text PDF (48 KB)
O16 Irregular antibodies in the neonates S. Benkö, J. Jakab, I. Zsigmond-Soós, Zs. Kristófi, N. Bedekovics page S72 Full-Text PDF (48 KB)
O17 Frequency of red blood cell antibodies in adult patients E. Gazdag, J. Jakab, I. Zsigmond-Soós, N. Golács, S. Benkö, M. Vagner, Zs. Kristófi, N. Bedekovich page S72 Full-Text PDF (48 KB)
O18 Evaluation of the influence of storage time and prestorage leucodepletion on the accumulation of platelet derived biologic response modifiers in platelet concentrates N.M. Zahran pages S72-S73 Full-Text PDF (58 KB)
O19 Clinicopathologic analisis and survival of 151 patients with T- and NK-cell lymphomas at the Federal Research Hematology Center of Russian Academy of Medical Sciences: a retrospective study Y.E. Vinogradova, I.N. Lutsenko, R.S. Samoilova, I.B. Kaplanskaya, I.A. Vorobiev, B.V. Zingerman, N.B. Rijicova, N.E. Shklovskiy-Kordi, E.A. Giliazitdinova, O.V. Margolin, D.C. Maryin, A.M. Krementskaya, S.K. Kravchenko, L. Varticovski, E. Jaffe, A.I. Vorobiev page S73 Full-Text PDF (49 KB)
O20 Intensified CHOP as first line treatment in poor risk diffuse large B cell non Hodgkin's lymphoma (DLBCL) patients A. Abdel Warith, Th. Abdel Hamid, N. Mokhtar, H. Dawood page S73 Full-Text PDF (49 KB)
O21 A retrospective single-center experience with bortezomib-based therapy of relapsed and/or refractory multiple myeloma: survival results of our first 104 consecutive patients G. Mikala, A. Batai, I. Bodo, Z. Csukly, J. Dolgos, G. Halm, J. Janosi, B. Kapas, N. Lovas, S. Lueff, M. Peto, P. Remenyi, A. Sipos, Z. Toth, T. Masszi pages S73-S74 Full-Text PDF (60 KB)
O22 Genetic lesions in multiple myeloma: prognostic and predictive significance in the era of the new drugs R. Hajek, P. Kuglik, R. Zaoralova, H. Greslikova, P. Nemec, J. Smejkalova page S74 Full-Text PDF (47 KB)
O23 Proliferation and apoptosis in multiple myeloma prognostic factors or kinetic parameters? J. Minarik, V. Scudla, M. Ordeltova, J. Bacovsky, M. Zemanova, T. Pika page S74 Full-Text PDF (47 KB)
O24 Immunological role of pathological phenotype in peripheral T-cell lymphoma L. Krenács, E. Bagdi pages S74-S75 Full-Text PDF (57 KB)
O25 The outcome of hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis in Korea T. Hwang, J. Seo, H. Youn, J. Song, H. Im, H. Moon, M. Lee, T. Ghim, H. Shin, H. Ahn, K. Seong, H. Koo, D. Jeong, B. Cho, H. Kim, H. Kook page S75 Full-Text PDF (45 KB)
O26 A pilot study with autologous bone marrow-derived stem cell transplantation (ABSCT) in patients with severe peripheral arterial disorder (SPAD) Z. Boda, K. Farkas, J. Tóth, L. Jámbor, P. Soltész, K. Rázsó, T. Sipos, M. Szarvas, Zs. Oláh, P. Ilonczai, K. Litauszky, Z. Veréb, E. Rajnav¨olgyi page S75 Full-Text PDF (45 KB)
O27 Present state of stem cell transplantation in Slovakia M. Mistrík, J. Horáková, J. Hudeček, J. Lakota, I. Markuljak, S. Palašthy, E. Tóthová pages S75-S76 Full-Text PDF (56 KB)
O28 Outcome of sibling reduced-intensity conditioning allogeneic stem cell transplantations in low-grade B cell lymphoproliferative disorders M. Dávid, R. Desmond, E. Conneally, P. Browne, S. McCann, M. Ni Chonghaile, E. Vandenberghe page S76 Full-Text PDF (46 KB)
O29 A novel treosulfan fludarabine (TreFlu) conditioning before allogeneic hematopoietic cell transplantation searching for reduced toxicity while preserving the treatment efficacy J. Holowiecki, S. Giebel, J. Wojnar, M. Krawczyk-Kulis, I. Wylezol, K. Wozniczka, T. Czerw, M. Markiewicz, A. Holowiecka-Goral, K. Jankowska page S76 Full-Text PDF (46 KB)
O31 Failure of puberty in Egyptian beta-thalassemic patients: experience in North East Region Dakahlia Province N. Abdelrazik, H. Ghanem pages S76-S77 Full-Text PDF (66 KB)
O32 Skin iron concentration, a simple, highly sensitive method for iron stores in thalassemia patients A. El-Beshlawy, I. Youssry, N.A. Mohsen, O.G. Shaker, A. El-Hennawy, R. Fawzy, N.M. Abu-Zeid page S77 Full-Text PDF (56 KB)
O33 Plasmodium falciparum malaria and painful crisis in adults with sickle cell anaemia in endemic areas: what's new? N.O. Akinola, R.A. Bolarinwa, A.O. Aboderin, M.A. Durosinmi page S77 Full-Text PDF (56 KB)
O34 Partial glutathione reductase deficiency as a modifying factor of variable clinical manifestation of unstable hemoglobinopathy R. Solna, P. Dolezel, P. Mlejnek, V. Divoky pages S77-S78 Full-Text PDF (66 KB)
O35 A prognostic impact of transfusion dependency on survival of patients with early myelodysplastic syndrome J. Čermák, P. Kačírková, D. Mikulenková, K. Michalová page S78 Full-Text PDF (49 KB)
O36 Factors of imatinib resistance in chronic myeloid leukemia B. Kajtár, D. Alpár, J. Tóth, R. László, P. Jáksó, L. Kereskai, Z. Nagy, L. Pajor page S78 Full-Text PDF (49 KB)
O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia H. Andrikovics, N. Meggyesi, S. Lueff, A. Batai, E. Adam, A. Kozma, G. Halm, S. Nahajevszky, B. Kapás, Z. Csukly, N. Lovas, P. Reményi, A. Tordai, T. Masszi pages S78-S79 Full-Text PDF (59 KB)
O38 Anagrelid in the treatment of essential thrombocytemia a single institution experience M. Hrubiško, Z. Štefániková, M. Mistrík page S79 Full-Text PDF (46 KB)
O39 Treatment of chronic myeloid leukemia in Northern Moravia: results during the period 1990 2005 E. Faber, J. Zapletalová, I. Skoumalová, M. Holzerová, J. Veselovská, Š. Rožmanová, P. Rohoň, R. Solná, L. Raida, I. Marešová, N. Klusová, V. Divoký, M. Jarošová, K. Indrák page S79 Full-Text PDF (46 KB)
O40 Results of the interferon-alpha 2b therapy in patients with Ph-negative chronic myeloproliferative disorder M.A. Sokolova, N.D. Khoroshko, N.V. Tsvetaeva, M.D. Sanatko, A.V. Misurin, V.V. Tihonova pages S79-S80 Full-Text PDF (59 KB)
O41 What is the best treatment strategy for Budd-Chiari patients with JAK2 mutation? P. Reményi, Zs. Gerlei, T. Masszi page S80 Full-Text PDF (49 KB)
O42 WT1 gene expression is significantly inhibited by vorinostat and bortezomib S. Galimberti, M. Canestraro, R. Khan, G. Buda, E. Orciuolo, F. Guerrini, R. Fazzi, M. Petrini page S80 Full-Text PDF (49 KB)
O43 ABCB1 multi drug transporter in detergent resistant plasma membrane microdomains Sz. Modok, A. Taylor, Z. Borbényi, A. Horváth, R. Callaghan page S80 Full-Text PDF (49 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
